University Of Maryland Medicine Launches Precision Health Study to Create Biggest and Most Diverse Research Database in State

Published on : Published by : BioBuzz Media

University of Maryland Medicine, the joint enterprise of the University of Maryland School of Medicine, the University of Maryland Medical Center, and University of Maryland Medical System, today launched a landmark initiative called My Healthy Maryland Precision Medicine Research. The project aims to enroll 250,000 Maryland residents over the next decade who reflect the diversity of the state and want to play a pivotal role in helping researchers understand how genes and lifestyle affect an individual’s health.

Gain Raises $40 Million in IPO, Funds Will Advance Rare Disease Pipeline

Published on : Published by : Alex Keown

Gain Therapeutics made its debut on the Nasdaq Thursday with a $40 million initial public offering. The company will use the funds to advance the development of its pipeline of therapeutics for rare genetic diseases characterized by protein misfolding.

Gain Therapeutics and UMSOM Partner to Investigate Small Molecule Drugs

Published on : Published by : Alex Keown

Gain Therapeutics and the University of Maryland School of Medicine forged a research collaboration to investigate Gain’s structurally targeted allosteric regulators (STARs) in cellular models of neuronopathic Gaucher disease (nGD) and Parkinson’s disease (PD).